Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)JC5
JournalAnnals of internal medicine
Volume160
Issue number6
DOIs
StatePublished - Mar 18 2014

ASJC Scopus subject areas

  • Internal Medicine

Cite this